Prevalence and clinical outcomes of KRASG12C mutated advanced lung cancer patients in Australia

Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2021
This article has no abstract
Epistemonikos ID: 3c75ae3dfdb14b16ed5038e30ce8c9a526063320
First added on: Mar 18, 2025